Compare DECK & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DECK | CNC |
|---|---|---|
| Founded | 1973 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 32.9B |
| IPO Year | 1996 | 2001 |
| Metric | DECK | CNC |
|---|---|---|
| Price | $82.36 | $68.12 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 29 | 21 |
| Target Price | ★ $96.98 | $76.00 |
| AVG Volume (30 Days) | 3.3M | ★ 5.0M |
| Earning Date | 10-22-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.90 | N/A |
| EPS | 3.24 | ★ 5.15 |
| Revenue | $5,472,296,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $4.25 | $13.71 |
| Revenue Next Year | $5.67 | N/A |
| P/E Ratio | $25.16 | ★ $14.10 |
| Revenue Growth | 9.76 | ★ 19.44 |
| 52 Week Low | $77.37 | $31.63 |
| 52 Week High | $122.29 | $78.08 |
| Indicator | DECK | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 45.02 | 47.80 |
| Support Level | $77.64 | $63.74 |
| Resistance Level | $83.00 | $68.67 |
| Average True Range (ATR) | 3.31 | 3.27 |
| MACD | -0.56 | -0.11 |
| Stochastic Oscillator | 16.61 | 27.74 |
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2026, Ugg and Hoka accounted for 50% and 47% of total sales, respectively. The firm also markets a niche sandal brand Teva. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has more than 200 company-operated stores, about half of which are outlets. The firm generated 58% of its fiscal 2026 sales in the United States.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.